Village Farms International, Inc. VFF, -5.94% (VFF) is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms International, Inc. recently announced that it has entered into an agreement with Nature Crisp LLC to form a joint venture for the outdoor cultivation of high-cannabidiol (CBD) hemp and CBD extraction in multiple states throughout the United States.
The joint venture, Village Fields Hemp, will be 65% owned by Village Farms and 35% owned by Nature Crisp. Nature Crisp is a private, Georgia based farming operation and part of the Jennings agricultural group of companies, which grows a diverse range of food and other crops, including hemp, on more than 6,000 acres in the U.S. and Canada.
"Jennings Group is a pioneer in hemp cultivation and this joint venture establishes a new powerhouse in hemp cultivation that significantly advances Village Farms' vertically integrated CBD strategy," said Michael DeGiglio, Chief Executive Officer, Village Farms. "
As 10 the generation farmers since Gideon (Zanini) Jennings immigrated to South Carolina in 1736, Jennings Group brings deep knowledge in large-scale field agriculture across a vast array of crops, with a proven track record of genetic optimization and innovation.
Over the past several years, they have rapidly become a leading authority on hemp cultivation, renowned for their understanding of the plant and their success applying their cultural and genetic expertise to meaningfully improve CBD content and yield.
Moreover, the Jennings Group team brings extensive relationships with the farming community across the U.S., as well as with geneticists, academics and researchers, that will be invaluable to the success of this new business."
https://www.marketwatch.com/press-release/cbd-products-continue-to-gain-traction-in-markets-around-the-globe-2019-04-08-920200?mod=mw_quote_news
Monday, April 8, 2019
Village Farms International, Inc. VFF.to
Tuesday, April 2, 2019
Is Cron a Buy Or A Sell?
The Healthcare stock (Cronos Group Inc.) showed a change of 0.05 percent from opening and finally turned off its business at $18.61 by scoring 0.98 percent (Gain, ↑) on 01-04-2019 (Monday). Cronos Group Inc., belongs to Healthcare sector and Biotechnology industry.
Historical Performance Review:
To realize the smear picture speculators will ought to to look rather more profound. The Cronos Group Inc. has seemed a 5.0 days execution of -9.35% and thirty days execution remains at -14.28%. The stock has seemed a ninety days performance of 78.6% and a six months act remains at 70.11%.
Market Capitalization/Outstanding Shares/Intraday Volume:
The company’s Market capitalization is $3.33B with the total Outstanding Shares of 178.71M. Market capitalization refers to the entire dollar market cost of a company’s outstanding shares. Referred to as “market cap,” it is determined by doubling a company’s shares outstanding by the current market price of one share. Outstanding shares refer to a company’s stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders.
The Cronos Group Inc. exchanged hands with 5288984 shares compared to its average daily volume of 16.32M shares.
Institutional Ownership/ Insider Ownership:
Cronos Group Inc. institutional ownership is held at 9.25% while insider ownership was 48.4%.
P/S, P/E, P/C and P/B/ SMA50, SMA 200:
The price-to-sales is a valuation ratio that relates a company’s stock price to its revenues. The price-to-sales ratio is a symbol of the value placed on each dollar of a company’s sales or taxes. As of now, CRONhas a P/S, P/E and P/B values of 0, 0 and 19.93 respectively.
Its P/Cash valued at 0. The price-to-cash-flow ratio is a stock valuation indicator that measures the value of a stock’s price to its cash flow per share
The stock has observed its SMA50 which is now -7.46%. In looking the SMA 200, we see that the stock has seen an 56.63%.The Company’s net profit margin for the 12-months at 0%. Comparatively, the company has a Gross margin 0%.
Earnings per Share Details of Cronos Group Inc.:
The EPS of CRON is strolling at -0.03, assessing its EPS improvement this year at 0%. In this manner, the company has Earnings per Share (EPS) growth of 0% for the coming year. Given the importance of identifying companies that will ensure earnings per share at a high rate, we later obsession to umpire how to determine which companies will achieve high amassing standards.
Target Price/Analysts Mean Suggestion:
Mostly, a price target is an individual analyst’s craving on the future price of a security, generally a stock. There may be many price targets for only protection. Analyst’s mean target cost for the company is $0 while specialists mean proposal is 0.
Beta/Volatility:
A beta factor is used to gauge the unpredictability of the stock. A Beta component of the stock stands at 0. Beta element is utilized to gauge the unpredictability of the stock. The stock remained 8.16% flighty for the week and 6.8% for the month.
While Shares of Costco Wholesale Corporation (NASDAQ: COST) constructed a change of 0.85% (Gain, ↑) and closed at $244.19. Cronos Group Inc. is an exciting player in the Services space, with a center of attention on Discount, Variety Stores.
Notable Indicators to Watch:
Traders seeking a better understanding of the stock can look at the underlying technical data. The company has 438.21M shares outstanding with 0.4% insider ownership. Volatility is just a measure of the predictable daily price range—the range in which a day trader operates. More evaporation means more significant profit or loss. After a recent check, (NASDAQ: COST) stock is found to be 0.9% volatile for the week, while 1.32% volatility recorded for the month with ATR of 3.06.
What do we know by simple moving average(SMA)?
A simple moving average is an indicator that calculates the average price of a security over a specified number of periods. If security is exceptionally volatile, then a moving average will assist to smooth the data. A moving average filters out random noise and offers a smoother perspective of the price action. The stock is trading away to its 50-day and 200-day moving averages by 10.45% and 10.21%, respectively. The price target set for the stock is $240.78, and this sets up an impressive set of potential movement for the stock.
Why is EPS essential to watch?
The current EPS for the company has recorded at $7.58. To calculate EPS, you take the profits left over for shareholders and divide by the number of shares outstanding. As a result, the company has an (Earning per Share) EPS growth of 6.87% for the coming year. Company’s EPS for the prior five-years is valued at 0%, leading it to an EPS value of 10.82% for the next five years.
Execution Review:
Taking an investigate the execution of COST stock, a financial specialist will come to realize that the week by week execution for this stock is esteemed at 3.05%, bringing about a performance for the month at 2.3%. The year-to-date (YTD) execution mirrored at 19.87 percent. Throughout the prior 3-months, the stock performs 20.86 percent, turning over six-month performance to 4.35 percent.
Understanding PE gives the shareholders an idea if the stock has sufficient growth potential. Stocks with low PE can be considered good bargains as their growth potential is still unknown to the market. As COST has a P/S, P/E and P/B estimations of 0.73, 32.22 and 7.76 separately.
Subscribe to:
Posts (Atom)